|
Stelios Papadopoulos, Ph.D., retired as Vice Chairman of Cowen & Co. LLC in August 2006 after six years as an investment banker with the firm, where he focused on the biotechnology and pharmaceutical sectors. Prior to joining Cowen & Co., he spent 13 years as an investment banker at PaineWebber Inc., where he was most recently Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. Dr. Papadopoulos is affiliated with New York University Medical Center as an Adjunct Associate Professor of Cell Biology. Dr. Papadopoulos is a co-founder and Chairman of the board of Exelixis Inc., a drug discovery and development company. He is also co-founder and member of the boards of directors of Anadys Pharmaceuticals Inc., a drug discovery and development company, and Cellzome Inc., a privately held drug discovery company. He is a member of the board of directors of Neuronyx Inc. and vice chairman of the board of directors of BG Medicine Inc., both privately held life sciences companies. In the not-for-profit sector, Dr. Papadopoulos is co-founder and Chairman of Foundation Sante, a member of the board of visitors of Duke University Medical Center and a member of the board of directors of the National Marrow Donor Program. Dr. Papadopoulos began serving as a director of Biogen Idec in 2008. | 